Effective Use of Keishibukuryogan in Subcutaneous Hematoma after Implantable Cardiac Device Surgery in Two Cases

Keishibukuryogan is a Kampo medicine that induces vasodilation and improves the blood flow velocity in subcutaneous blood vessels. We herein report two cases in which keishibukuryogan completely diminished subcutaneous hematoma after cardiac resynchronization therapy pacemaker implantation and defib...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumanomido, Jun, Ohe, Masatsugu, Shibata, Ryo, Hattori, Yuichi, Ishizaki, Yuta, Ito, Shogo, Nohara, Yume, Takahashi, Jinya, Hori, Kensuke, Obuchi, Aya, Ohtsuka, Masanori, Fukumoto, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990628/
https://www.ncbi.nlm.nih.gov/pubmed/33028772
http://dx.doi.org/10.2169/internalmedicine.5677-20
Descripción
Sumario:Keishibukuryogan is a Kampo medicine that induces vasodilation and improves the blood flow velocity in subcutaneous blood vessels. We herein report two cases in which keishibukuryogan completely diminished subcutaneous hematoma after cardiac resynchronization therapy pacemaker implantation and defibrillator battery replacement within a month. Keishibukuryogan can be a good option for treating or preventing subcutaneous hematoma after surgical procedures for devices.

Ejemplares similares